ReviewJournal of clinical microbiology2018
Rapid Antigen Tests for Influenza: Rationale and Significance of the FDA Reclassification.
Daniel A Green et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papercites it